Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cowealth Medical Holding Co's quarterly Total Liabilities
declined
from Jun. 2025 (NT$2,140.38 Mil) to Sep. 2025 (NT$1,940.14 Mil) but then
increased
from Sep. 2025 (NT$1,940.14 Mil) to Dec. 2025 (NT$1,985.42 Mil).
Cowealth Medical Holding Co's annual Total Liabilities
increased
from Dec. 2023 (NT$1,606.94 Mil) to Dec. 2024 (NT$1,764.13 Mil) and
increased
from Dec. 2024 (NT$1,764.13 Mil) to Dec. 2025 (NT$1,985.42 Mil).
Cowealth Medical Holding Co Total Liabilities Related Terms
Cowealth Medical Holding Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co Total Liabilities Chart
Cowealth Medical Holding Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Cowealth Medical Holding Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of NT$1,985 Mil mean?
Cowealth Medical Holding Co (ROCO:4745) has a Total Liabilities of NT$1,985 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cowealth Medical Holding Co and its competitors.
Is Cowealth Medical Holding Co's Total Liabilities too high?
Cowealth Medical Holding Co's current Total Liabilities is NT$1,985 Mil. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Total Liabilities compare to ABT and SYK?
Cowealth Medical Holding Co's Total Liabilities of NT$1,985 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cowealth Medical Holding Co and its competitors. Cowealth Medical Holding Co's current Total Liabilities is NT$1,985 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.10, compared to a current price of NT$13.85 — trading 5.7% above its estimated fair value. The current Total Liabilities is NT$1,985 Mil. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Total Liabilities is NT$1,985 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued.
The current stock price of NT$13.85 is trading 5.7% above its estimated GF Value™ of NT$13.10.
GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.
Key valuation signals for ROCO:4745:
Total Liabilities: NT$1,985 Mil
GF Value™: NT$13.10 vs. price of NT$13.85 (5.7% above fair value)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score
Get the complete analysis for ROCO:4745
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
